Sign In
Buy TEVA
$34.72
+0.290 (+0.84%)
At Close: Aug 05, 2026
Teva's (TEVA) NDA for Schizophrenia Drug Gets FDA Acceptance
01:47pm, Wednesday, 01'st Sep 2021
The FDA accepts Teva Pharmaceuticals (TEVA) and partner MedinCell's new drug application for risperidone, a potential treatment for schizophrenia.
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
07:27am, Wednesday, 01'st Sep 2021
The FDA has accepted Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and MedinCell's marketing application seeking approval for TV-46000/mdc-IRM in schizophrenia. TV-46000/mdc-IRM is a risperid
PARSIPPANY, N.J., TEL AVIV & PARIS--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced toda
3 Generic Drug Stocks to Watch Amid Pandemic & Pricing Pressure
12:10pm, Tuesday, 17'th Aug 2021
The impact of the coronavirus pandemic on the Zacks Medical-Generic Drugs industry is expected to recede in the second half of 2021. Moreover, stable pricing and improving demand in some countries in
Digging into the moves in big cap pharma
07:13pm, Monday, 16'th Aug 2021
Retailers are on deck to report earnings this week, but some macro headwinds could create uncertainty for the group.
Why Teva Pharmaceuticals Has Two A-Products In The Bag
04:38pm, Tuesday, 10'th Aug 2021
Why Teva Pharmaceuticals Has Two A-Products In The Bag
Teva: Maximum Optimism
03:35pm, Wednesday, 04'th Aug 2021
Teva is one of the largest pharmaceutical companies in the world and the second largest generic medicine company (after Viatris) in terms of revenue.
TEVA Q2 Earnings Beat Estimates, Revenues Miss, Stock Up
12:10pm, Thursday, 29'th Jul 2021
TEVA beats on second-quarter earnings but misses on sales. The company lowers 2021 sales view.
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q2 2021 Results - Earnings Call Transcript
01:43pm, Wednesday, 28'th Jul 2021
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q2 2021 Results - Earnings Call Transcript
Teva Stock Falls After COVID-19 Impacts Q2 Top And Bottomline; Lowers FY21 Outlook
08:47am, Wednesday, 28'th Jul 2021
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 sales reached $3.9 billion, increasing 1% Y/Y or decreasing 2% in local currency terms, missing the consensus of $4.04 billion. The decrease was ma
Teva revenue falls short of estimates, lowers guidance as pandemic continue to weigh
07:34am, Wednesday, 28'th Jul 2021
Teva Pharmaceutical Industries Ltd.'s shares slid 2.5% in premarket trade Wednesday, after the Israeli generics maker missed revenue estimates for the second quarter and lowered guidance, citing the c
Recap: Teva Pharmaceutical Q2 Earnings
07:24am, Wednesday, 28'th Jul 2021
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) fell 2.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 7.27% year over year to $0.59, whi
Will Teva Stock Rebound After A 10% Fall In A Month?
09:00am, Thursday, 08'th Jul 2021
We believe that Teva Pharmaceutical stock is a good buying opportunity at the present time. TEVA stock trades near $10 currently and it is, in fact, down 28% from its pre-Covid high of around $13 in F
Warren Buffett's 6 Worst-Performing Stocks in Q2
08:53am, Tuesday, 06'th Jul 2021
As of March 31, Warren Buffett's Berkshire Hathaway Inc. (NYSE: BRK-B) had 48 stocks in its portfolio.
What To Do After Teva Stock Falls Below $10 Again
09:40pm, Monday, 05'th Jul 2021
Teva stock abruptly fell below $10 last week. Markets ignore two key product drivers for free cash flow growth.
